Search | Page 24 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: What do hospitalists need to know?

    ... with MDS develop the disorder as a result of previous chemotherapy or radiation as treatment for another malignancy.  There are ... (Vidaza®) and decitabine (Dacogen®), intensive chemotherapy, and stem cell transplantation.  Patients tend to tolerate ...

    Research Review last updated 05/02/2016 - 9:21am.

  2. Nonmyeloablative Haploidentical Transplant Followed by MLN9708

    ... blast crisis in 2nd chronic phase following induction chemotherapy ) Acute Myelogenous Leukemia (2nd or subsequent complete remission [CR] (OR) Primary induction chemotherapy failure, but subsequently entered into a CR(OR) 1st CR with poor ...

    Clinical Trial last updated 04/29/2016 - 1:05pm.

  3. Heather Putney’s Trials (and Travels) with Aplastic Anemia

    ... My husband and I understood that due to the limited chemotherapy , I had a 50% chance of maintaining fertility.  Prior the ...

    Patient Chronicle last updated 08/15/2016 - 8:42am.

  4. MDS Patient Becomes a Role Model

    ... in my mother’s footsteps, in November of 2013 I had chemotherapy and radiation followed by a bone marrow transplant from an ... in my feet (tingling, pain, numbness or weakness) from the chemotherapy, radiation, and all of the medication I had to take for the ...

    Patient Chronicle last updated 04/22/2016 - 5:19pm.

  5. TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate

    ... metastases and did not achieve a CR with surgery and/or chemotherapy Karnofsky (patients > 16 years) or Lansky ... have fully recovered from acute toxic effects of all prior chemotherapy, immunotherapy, or radiotherapy prior to entering this study ...

    Clinical Trial last updated 04/29/2016 - 4:35pm.

  6. Options for MDS patients beyond HMAs

    ... including:  low dose cytarabine; aggressive chemotherapy ; switching to the other of the two HMAs – preferably ...

    Research Review last updated 05/02/2016 - 9:09am.

  7. Lukasz Gondek, M.D., Ph.D.

    ... cells self-renewal, proliferation, and resistance to chemotherapy . Results of this study may contribute to more accurate ...

    Bio last updated 03/11/2016 - 1:41pm.

  8. Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor

    ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  9. What are the treatments for MDS?

    ... (Dacogen) and azacitidine (Vidaza). Chemotherapy :  Treats MDS by using drugs that kill abnormal cells. ...

    FAQ last updated 03/15/2016 - 11:31pm.

  10. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... significant toxicities Grade ≥2 from previous chemotherapy not readily controlled by supportive measures (excluding ... nausea, and fatigue) Patient has received treatment with chemotherapy, wide-field radiation, or biologic therapy within 14 days of study ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.